Treatments

Will There Be a Cure For Waldenstrom Macroglobulinemia?

What progress has been made in research for WM and what is the role of targeted therapies in providing a cure for Waldenstrom macroglobulinemia?

Andrew Schorr, Stephen M. Ansell, MD, PhD

How Are BTK Inhibitors Changing Waldenstrom Patients' Outcomes?

Dr. Steven Treon explains how BTK inhibitors are improving treatment options for Waldenstrom macroglobulinemia patients.

Andrew Schorr, Steven Treon, MD

Latest News

When Should a Patient Seek Treatment for Waldenstrom Macroglobulinemia?

Andrew Schorr, Steven Treon, MD

Current and Future Treatments for Waldenstrom Macroglobulinemia

Andrew Schorr, Jorge Castillo, MD

Watch and Wait for Waldenstrom Macroglobulinemia

James Berenson, MD, Andrew Schorr

Can Waldenstrom Drug Ibrutinib Be Used as COVID-19 Treatment?

Innovative Treatment Options for Waldenstrom

Lauren Evoy Davis

Maintenance Therapy for Waldenstrom: Necessary or Not?

Larry Anderson, Jr., MD, PhD, Theresa Clementi Doan

Waldenstrom Macroglobulinemia: Symptoms and Treatment

Larry Anderson, Jr., MD, PhD

Waldenstrom Diagnosis: Consulting a Specialist for Help

Sikander Ailawadhi, MD, Esther Schorr

Treatment Options for Waldenstrom Are Evolving

Steven T. Rosen, MD, Esther Schorr

Waldenstrom Patients Benefit From Treatments Developed for Myeloma and Lymphoma

James Berenson, MD, Esther Schorr

Treating Waldenstrom With Targeted Therapies

Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Dan Vogl, MD